Literature DB >> 35759450

MicroRNA cargo of extracellular vesicles released by skeletal muscle fibro-adipogenic progenitor cells is significantly altered with disuse atrophy and IL-1β deficiency.

Emily Parker1, Bharati Mendhe1, Ling Ruan1, Brendan Marshall2, Wenbo Zhi3, Yutao Liu1, Sadanand Fulzele1, Yao Liang Tang4, Meghan McGee-Lawrence1, Tae Jin Lee3, Ashok Sharma3, Maribeth Johnson5, Jie Chen5, Mark W Hamrick1.   

Abstract

Fibro-adipogenic progenitor cells (FAPs) are a population of stem cells in skeletal muscle that play multiple roles in muscle repair and regeneration through their complex secretome; however, it is not well understood how the FAP secretome is altered with muscle disuse atrophy. Previous work suggests that the inflammatory cytokine IL-1β is increased in FAPs with disuse and denervation. Inflammasome activation and IL-1β secretion are also known to stimulate the release of extracellular vesicles (EVs). Here, we examined the microRNA (miRNA) cargo of FAP-derived, platelet-derived growth factor receptor A (PDGFRα+) EVs from hindlimb muscles of wild-type and IL-1β KO mice after 14 days of single-hindlimb immobilization. Hindlimb muscles were isolated from mice following the immobilization period, and PDGFRα+ extracellular vesicles were isolated using size-exclusion chromatography and immunoprecipitation. Microarrays were performed to detect changes in miRNAs with unloading and IL-1β deficiency. Results indicate that the PDGFRα+, FAP-derived EVs show a significant increase in miRNAs, such as miR-let-7c, miR-let-7b, miR-181a, and miR-124. These miRNAs have previously been demonstrated to play important roles in cellular senescence and muscle atrophy. Furthermore, the expression of these same miRNAs was not significantly altered in FAP-derived EVs isolated from the immobilized IL-1β KO. These data suggest that disuse-related activation of IL-1β can mediate the miRNA cargo of FAP-derived EVs, contributing directly to the release of senescence- and atrophy-related miRNAs. Therapies targeting FAPs in settings associated with muscle disuse atrophy may therefore have the potential to preserve muscle function and enhance muscle recovery.

Entities:  

Keywords:  PDGFRα; let-7 family; miR-124; miR-181a; senescence

Mesh:

Substances:

Year:  2022        PMID: 35759450      PMCID: PMC9342138          DOI: 10.1152/physiolgenomics.00177.2021

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   4.297


  55 in total

1.  Circulating microRNAs after a 24-h ultramarathon run in relation to muscle damage markers in elite athletes.

Authors:  Emeric Chalchat; Keyne Charlot; Sebastian Garcia-Vicencio; Pierre Hertert; Stéphane Baugé; Stéphanie Bourdon; Julie Bompard; Cédric Farges; Vincent Martin; Cyprien Bourrilhon; Julien Siracusa
Journal:  Scand J Med Sci Sports       Date:  2021-05-22       Impact factor: 4.221

2.  Deficiency of the mitochondrial phosphate carrier presenting as myopathy and cardiomyopathy in a family with three affected children.

Authors:  Johannes A Mayr; Franz A Zimmermann; Rita Horváth; Hans-Christian Schneider; Benedikt Schoser; Elke Holinski-Feder; Birgit Czermin; Peter Freisinger; Wolfgang Sperl
Journal:  Neuromuscul Disord       Date:  2011-07-16       Impact factor: 4.296

3.  HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells.

Authors:  Martina Sandonà; Silvia Consalvi; Luca Tucciarone; Marco De Bardi; Manuel Scimeca; Daniela Francesca Angelini; Valentina Buffa; Adele D'Amico; Enrico Silvio Bertini; Sara Cazzaniga; Paolo Bettica; Marina Bouché; Antonella Bongiovanni; Pier Lorenzo Puri; Valentina Saccone
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

Review 4.  Noncoding RNA control of cellular senescence.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-09-01       Impact factor: 9.957

5.  Tissue-Resident PDGFRα+ Progenitor Cells Contribute to Fibrosis versus Healing in a Context- and Spatiotemporally Dependent Manner.

Authors:  Maria Paola Santini; Daniela Malide; Gabriel Hoffman; Gaurav Pandey; Valentina D'Escamard; Aya Nomura-Kitabayashi; Ilsa Rovira; Hiroshi Kataoka; Jordi Ochando; Richard P Harvey; Toren Finkel; Jason C Kovacic
Journal:  Cell Rep       Date:  2020-01-14       Impact factor: 9.423

6.  miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets.

Authors:  Tzu-Pin Lu; Chien-Yueh Lee; Mong-Hsun Tsai; Yu-Chiao Chiu; Chuhsing Kate Hsiao; Liang-Chuan Lai; Eric Y Chuang
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

7.  miR‑20b inhibits the senescence of human umbilical vein endothelial cells through regulating the Wnt/β‑catenin pathway via the TXNIP/NLRP3 axis.

Authors:  Feifei Dong; Shaohua Dong; Ying Liang; Ke Wang; Yongwen Qin; Xianxian Zhao
Journal:  Int J Mol Med       Date:  2020-01-08       Impact factor: 4.101

8.  Hypoxia-Induced miR-210 Is Necessary for Vascular Regeneration upon Acute Limb Ischemia.

Authors:  Germana Zaccagnini; Biagina Maimone; Paola Fuschi; Marialucia Longo; Daniel Da Silva; Matteo Carrara; Christine Voellenkle; Laura Perani; Antonio Esposito; Carlo Gaetano; Fabio Martelli
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

9.  Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes.

Authors:  Petr Dmitriev; Ana Barat; Anna Polesskaya; Mary J O'Connell; Thomas Robert; Philippe Dessen; Thomas A Walsh; Vladimir Lazar; Ahmed Turki; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  BMC Genomics       Date:  2013-04-18       Impact factor: 3.969

10.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.

Authors:  Eva van Rooij; Daniel Quiat; Brett A Johnson; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Robert J Kelm; Eric N Olson
Journal:  Dev Cell       Date:  2009-11       Impact factor: 13.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.